Tag Archives: Pediatric

Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.

Epilepsy Behav. 2018 Feb 8. pii: S1525-5050(18)30009-X. doi: 10.1016/j.yebeh.2018.01.026. [Epub ahead of print] Porcari GS1, Fu C2, Doll ED2, Carter EG2, Carson RP3. Author information Abstract Medically refractory epilepsy continues to be a challenge worldwide, and despite an increasing number of medical therapies, approximately 1 in 3 patients continues to have seizures. Cannabidiol (CBD), one […]

Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis.

J Neurol. 2017 Dec 22. doi: 10.1007/s00415-017-8715-5. [Epub ahead of print] Brenton JN1, Schreiner T2, Karoscik K3, Richter M3, Ferrante S3, Waldman A3, Banwell B3. Author information Abstract BACKGROUND: Studies have shown a negative impact on cognition and brain volume in marijuana-using adult multiple sclerosis (MS) patients and healthy adolescents. Given that onset of MS […]

Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.

Epilepsia. 2017 Jun 15. doi: 10.1111/epi.13815. [Epub ahead of print] Rosenberg EC1, Louik J2, Conway E2, Devinsky O2, Friedman D2. Author information Abstract Recent clinical trials indicate that cannabidiol (CBD) may reduce seizure frequency in pediatric patients with certain forms of treatment-resistant epilepsy. Many of these patients experience significant impairments in quality of life (QOL) […]

Treatment issues for children with epilepsy transitioning to adult care.

Epilepsy Behav. 2017 Feb 7. pii: S1525-5050(16)30631-X. doi: 10.1016/j.yebeh.2016.11.008. [Epub ahead of print] Nabbout R1, Camfield CS2, Andrade DM3, Arzimanoglou A4, Chiron C5, Cramer JA6, French JA7, Kossoff E8, Mula M9, Camfield PR10. Author information Abstract This is the third of three papers that summarize the second symposium on Transition in Epilepsies held in Paris in June 2016. This paper focuses on treatment issues that […]

Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.

Epilepsia. 2016 Nov 18. doi: 10.1111/epi.13617. [Epub ahead of print] Treat L1, Chapman KE1, Colborn KL2, Knupp KG1. Author information Abstract OBJECTIVE: Oral cannabis extracts (OCEs) are being used in the treatment of epilepsy with increasing rates in the United States following product legalization; however, no studies demonstrate clear efficacy. We evaluated the duration of use of OCEs as […]

Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High.

2016 Aug 30. [Epub ahead of print]Hoffenberg EJ1, Newman H, Collins C, Leinwand K, Tarbell S. Author information Abstract The trend towards decriminalization of cannabis (marijuana) continues sweeping across the United States. Colorado has been a leader of legalization of medical and recreational cannabis use. The growing public interest in the medicinal properties of cannabis and its use by […]

Characterization of Dronabinol Usage in a Pediatric Oncology Population.

2015 Nov-Dec;20(6):462-467. Elder JJ1, Knoderer HM2. Author information Abstract OBJECTIVES: Chemotherapy-induced nausea and vomiting (CINV) remains an important side effect associated with administration of chemotherapy in pediatrics. The aim of this study was to retrospectively review dronabinol use in a pediatric cancer center, with the intent of characterizing its use and identifying trends such as age, sex, diagnosis, and […]

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.

 2015 Apr 2;45:49-52. doi: 10.1016/j.yebeh.2015.02.043. [Epub ahead of print] Press CA1, Knupp KG1, Chapman KE2. Author information Abstract OBJECTIVE: Oral cannabis extracts (OCEs) have been used in the treatment of epilepsy; however, no studies demonstrate clear efficacy. We report on a cohort of pediatric patients with epilepsy who were given OCE and followed in a single tertiary epilepsy center. METHODS: […]

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Porter BE, Jacobson C. Source Department of Neurology, Stanford University, USA. Abstract Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments. This survey explored the use of cannabidiol-enriched cannabis in […]